NEW ORLEANS, LA (March 22, 2012) – As a leading provider of education and technology for combating healthcare-associated infections (HAIs) over the past 25 years, ASP will deliver an educational workshop on infection prevention at the 59th Annual Association of periOperative Registered Nurses (AORN) Congress taking place March 24-29, 2012 in New Orleans. The 30-minute workshop, titled “Elevating the Standard of Care through Operational Excellence: Updates in Reprocessing Semi-critical and Critical Devices,” will be presented at seven different session times on March 27-28 in the ASP exhibit booth (#3237), where ASP’s growing portfolio of infection prevention solutions will also be on display. Continuing Education (CE) study guides will be available.
“ASP shares a common mission with perioperative nurses to provide the safest possible healthcare environments and protect patients’ lives against infection,” says Barbara Trattler, ASP Director of Clinical Education. “With healthcare-associated infections on the rise, ASP cares deeply about offering education and support to help nurses influence safe perioperative practices and deliver the highest standards of care for their patients.”
Healthcare-associated infections (HAIs) occur in more than 2 million patients each year – approximately 5 percent to 10 percent of hospitalized patients – leading to approximately 90,000 deaths per year. [1][2]
CE Study Guides and Workshop Schedule
ASP’s educational workshop will focus on preventing patient infections through proper reprocessing of medical devices, including terminal sterilization and high-level disinfection methodologies. All workshop participants will receive a supporting study guide with a quiz that may be mailed in to receive two (2) CE credits.
Available Workshop Sessions at ASP Booth #3237:
- Tuesday, March 27: 10:15–10:45 a.m., 11:15–11:45 a.m., 1:15–1:45 p.m., 2:15–2:45 p.m.
- Wednesday, March 28: 10:15–10:45 a.m., 11:15–11:45 a.m., 1:15–1:45 p.m.
Workshop Instructors:
- Janet Moran, RN, MBA, CNOR (ASP Senior Clinical Education Consultant)
- Catherine K. Rocco, RN, MSN, CNOR(ASP Senior Clinical Education Consultant)
Exhibitof ASP Infection Prevention Solutions
In addition to participating in ASP’s educational workshop, conference attendees are welcome to visit the ASP exhibit booth to see the latest technology solutions for medical device sterilization and high-level disinfection – including trusted STERRAD® Systems, the ground-breaking EVOTECH® Endoscope Cleaner and Reprocessor (ECR), and proven biocides.
The booth will also feature an exhibit and demonstration of the most recent addition to ASP’s infection prevention portfolio, the GLOSAIR™ 600 System. GLOSAIR™ Technology is designed to combat dangerous pathogens in the healthcare environment – such as methicillin-resistant Staphylococcus aureus (MRSA), Influenza A Strain-Hong Kong, Influenza A (H5N1) and Rhinovirus— by creating a mist of hydrogen peroxide that is uniformly dispersed to disinfect all hard nonporous surfaces, including the nooks and crannies.
ASP’s team of knowledgeable infection prevention experts will be on hand at the booth throughout the conference to answer questions and support perioperative professionals in their quest to reduce HAIs at their facilities.
About ASP
ASP (Advanced Sterilization Products), a Johnson & Johnson company, is a global developer of innovative infection prevention solutions and educational programs. For 25 years, the company has been dedicated to protecting patients, healthcare workers, and the environment with technology, products, and services that focus on raising the standard of care. ASP is based in Irvine, California, USA with offices around the world. Please visit ASP at www.ASPJJ.com, on Facebook at www.Facebook.com/ASPJJ, follow us on Twitter @ASPJJ and see videos at http://www.youtube.com/user/InfectionPrevention.
ASP Media Contact:
Katie Sweet, ASP
ksweet@its.jnj.com
+1-949.789.3945
###
[1] Weinstein R. In: Kasper DL, et al. Harrison’s Principles of Internal Medicine. 16th ed. New York: McGraw Hill; 2004
[2] Burke JP. N Engl J Med. 2003; 348(7): 651-656.